All News
Blurred line indeed, one could argue that a patient with ACPA+, arthralgia and sub-clinical inflammation detected on MRI is already transitioning toward early RA and fall into the category of patients we should treat anyway. https://t.co/Y1JceOijK0
Aurelie Najm AurelieRheumo ( View Tweet)
If you've heard about Build Back Better in the news, and want to know if affects Rheumatology 👇
Thanks @ACRheumDC and #rheumpac for your help.
Looking forward to #ACR21 advocacy session Sunday at 11am! @zach_wallace_md @BlairSolowMD https://t.co/mDCzg0fXcU
Eric Dein ericdeinmd ( View Tweet)
#ACR21 is just days away and we want to see your best images of learning virtually, missing a meeting in San Francisco, wellness, or break time activities.
Tweet your pic and make sure to include #RheumPix and #ACR21 and we’ll share our favorites. https://t.co/UwaO9c6ODW
Dr. John Cush RheumNow ( View Tweet)
Thank you ACR Convergence Today for the interview and featuring my abstract ! #ACR21 @ACRheum
https://t.co/JISSTSDt1d https://t.co/roh5BSgbeD
Links:
Akhil Sood MD AkhilSoodMD ( View Tweet)
‘Activity based programs including physical activity and mindful based exercises can help to reduce pain. These are strategies to assist while managing from pharmacological standpoint.’ @UnaMakris
Akhil Sood MD AkhilSoodMD ( View Tweet)
‘We need to identify patients at increased risk for cognitive impairment.’ @MyasoedovaElena
Akhil Sood MD AkhilSoodMD ( View Tweet)
@KDAO2011 @Yuz6Yusof @drdavidliew @Janetbirdope @uptoTate @ericdeinmd @doctorRBC @synovialjoints @MeralElRamahiMD @DrMiniDey @_Castillo_Pedro @DrPetryna @AkhilSoodMD @swethaann23 @RHEUMarampa @RichardPAConway
Follow us!
Aurelie Najm AurelieRheumo ( View Tweet)
Also, yes I was sporting a beard for the recording #ACR21🧔 https://t.co/EK7N9X7zL7
Jeffrey Sparks MD MMSc jeffsparks ( View Tweet)
Kudos to this year’s recipients of the Distinguished Fellow Award! Distinguished Fellows → https://t.co/rS4IELAmd1 #ACR21 https://t.co/855fjYbPao
Links:
American College of Rheumatology ACRheum ( View Tweet)
@rheum_cat @KDAO2011 @RheumEpi @JYazdanyMD @RADoctor That too... so many great moments in this video... also this reaction --> 😕
😂😂😂 @alhkim https://t.co/kAYBgPk1aB
Jeffrey Sparks MD MMSc jeffsparks ( View Tweet)
When you sign up to bike the ACR Virtual 5k, but it’s 62 degrees and beautiful in MN in November, you keep going and make it 20k.#acr21 #RheumPix https://t.co/j1Smoga41r
Julie Jones 🏳️🌈🐈⬛🐈 JonesN4Rheum ( View Tweet)
and for those interested in the detail:
- remnant TAB divided and culture ex vivo with placebo, mavrilimumab, tocilizumab
- inflamm transcriptomics panel
- 81 differentially expressed genes assessed
- categorised by function https://t.co/0MWZk82Gj5
David Liew drdavidliew ( View Tweet)
Great start to #ACR21 and great recap of the year in rheumatology.
Positive data on tofacitinib and AS but still pending approval.
Where would JAKinibs be in your AS treatment algorithm?🤔
@RheumNow https://t.co/cs8U33355A
Robert B Chao, MD doctorRBC ( View Tweet)
#ACR21 Abst#0910 by @rheum_cat. Do TNFi ⬆️ risk of incident HTN in AxSpa?
⭐️PSOAS cohort: Prosp study from 2003-2018
▶️When adjusted for confounders (obesity, disease activity, NSAID use), insufficient evidence to show ⬆️ risk of HTN w TNFi
https://t.co/DCZ3W8CkOa @Rheumnow
Links:
Eric Dein ericdeinmd ( View Tweet)
Exciting day at #ACR21
I wrote an article discussing COVID 19 in #RheumatoidArthritis discussing the following abstracts
0097 by Hasseli
1445 by @NamrataRheum
L04 by @rheum_cat & @rheum_covid
@rheumnow #COVID19 #RA #JAK #Rituximab
https://t.co/g32ZYHBjQY
Akhil Sood MD AkhilSoodMD ( View Tweet)
#ACR21 Abst#0916. https://t.co/uc5JDVY0ud
Your patient has had 1 yr of remission of AxSpa on Certolizumab pegol, tolerating the medication. What do you recommend @Rheumnow
Links:
Eric Dein ericdeinmd ( View Tweet)
Dr. Thaissa Cotton on SLE + ILD and/or myositis: important given poorer outcomes. Ask pts and listen to those lungs!
💠1.8 cases/100 patient years (14/551 pts in study)
💠92.9% had >=1 med-to-high titer marker
💠⬆️risk if baseline +anti KL-6, Ku, CENPB
#ACR21 Abst#0330 @RheumNow
Pedro Castillo _Castillo_Pedro ( View Tweet)
#ACR21 Abst#0916
⭐️AxSpa pts in remission: Full Certolizumab vs 1/2 dose vs PBO
▶️ 85% w/o flare in full dose, 80% in 1/2 dose, just 23% in PBO
▶️ PBO pts with NO flare STILL showed ⬆️ ASDAS, BASDAI, and CRP
🔥Would ⬇️ not d/c Cimzia!
@Rheumnow https://t.co/uc5JDVY0ud #ACRBest https://t.co/fOssPlTEwR
Links:
Eric Dein ericdeinmd ( View Tweet)
We are live! Join us!
RheumNow Daily Recap - #ACR21 https://t.co/hUqx6B2ySD via @YouTube
Links:
Dr. John Cush RheumNow ( View Tweet)
Small numbers but mirrors data from TENOR and plenty to think about here. We clearly want to see sustained remission and Ax details, but very promising!
Definitely on the agenda for the @RheumNow #ACR21 GCA/PMR panel on Wed am with @LCalabreseDO @Sarah_L_Mackie @RichardPAConway
David Liew drdavidliew ( View Tweet)
